Mather Group’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Mather Group's LLY Position: Q3 2026 in Review
Mather Group increased its Eli Lilly (LLY) stake by 44% in Q3 2026, buying an estimated $4.75M and bringing the position to 13,156 shares worth $15.2M. The position accounts for 0.13% of the portfolio, ranked #81.
Mather Group first reported a position in LLY in Q1 2021 and has held it in 23 quarters since. 1,134 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- Mather Group held 13,156 shares of Eli Lilly worth $15.2M as of Q3 2026.
- Mather Group bought 4,024 Eli Lilly shares in Q3 2026, an estimated $4.75M.
- Eli Lilly made up 0.13% of Mather Group's portfolio in Q3 2026, its #81 holding.
- Mather Group first reported a position in Eli Lilly in Q1 2021 and has held it in 23 quarters since.
- 1,134 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on Mather Group's 13F filing for Q3 2026, filed 14 Oct 2026.